Home arrow Business arrow Pharmaceutical Industry
Business
Express Scripts expects FTC questions
AP   Friday, 09 March 2007

A CVS drugstore in Boston, November 1, 2006. CVS Corp. on Thursday again raised its takeover bid for Caremark Rx Inc. by sweetening a one-time dividend and said the new proposal was its 'best and final' offer. (Brian Snyder/Reuters)AP - Pharmacy Benefits Manager Express Scripts Inc. says it's expecting more questions from federal regulators this week over its proposal to acquire rival Caremark Rx Inc.


Read more...
CVS ups Caremark bid
Reuters   Friday, 09 March 2007

A CVS drugstore in Boston, November 1, 2006. CVS Corp. on Thursday again raised its takeover bid for Caremark Rx Inc. by sweetening a one-time dividend and said the new proposal was its 'best and final' offer. (Brian Snyder/Reuters)Reuters - CVS Corp. sweetened its $23.9 billion takeover bid for Caremark Rx Inc. on Thursday with an increased dividend, calling its newest proposal its "best and final" offer for the pharmacy-benefits manager.


Read more...
CVS ups Caremark bid again
Reuters   Friday, 09 March 2007

A CVS drugstore in Boston, November 1, 2006. CVS Corp. on Thursday again raised its takeover bid for Caremark Rx Inc. by sweetening a one-time dividend and said the new proposal was its 'best and final' offer. (Brian Snyder/Reuters)Reuters - CVS Corp. sweetened its $23.9 billion takeover bid for Caremark Rx Inc. on Thursday with an increased dividend, calling its newest proposal its "best and final" offer for the pharmacy-benefits manager.


Read more...
Teva gets FDA nod for generic version of Dostinex
Reuters   Friday, 09 March 2007
Reuters - Teva Pharmaceutical Industries Ltd. said the U.S. Food and Drug Administration has approved its generic version of Pharmacia & Upjohn Inc.'s Dostinex tablets to treat hyperprolactinemic disorders.
Read more...
Express tweaks Caremark offer after setbacks
Reuters   Thursday, 08 March 2007
Reuters - Express Scripts Inc. sweetened its bid for Caremark Rx Inc. on Wednesday after suffering two setbacks in its battle to wrest the rival pharmacy-benefit manager away from a $22.8 billion deal with CVS Corp.
Read more...
Senators promise drug importation push
Reuters   Thursday, 08 March 2007

Senator Byron Dorgan (D-ND) on Capitol Hill in a file photo. Senators vowed on Wednesday to move forward with legislation to legalize the importation of cheaper prescription drugs from certain countries, despite resistance from regulators and drugmakers. (Kevin Lamarque/Reuters)Reuters - U.S. senators vowed on Wednesday to move forward with legislation to legalize the importation of cheaper prescription drugs from certain countries, despite resistance from regulators and drugmakers.


Read more...
Drug imports battle heats up again
AP   Thursday, 08 March 2007
AP - The pharmaceutical lobby pushed back Wednesday against a renewed effort in Congress to pass a law enabling U.S. consumers to buy cheaper prescription drugs from Canada and other countries.
Read more...
Publicis acquires health-care services company
Reuters   Thursday, 08 March 2007
Reuters - Publicis , the world's fourth-largest advertising group, said on Wednesday it would acquire Pharmagistics, a pharmaceutical services company, in an effort to boost its health-care communications business.
Read more...
Novartis' New Blood Pressure Weapon
BusinessWeek Online   Wednesday, 07 March 2007
BusinessWeek Online - On Mar. 6, U.S. regulators gave Swiss pharmaceutical giant Novartis' new treatment for high blood pressure the green light. With Tekturna, the first in a new class of hypertension drugs known as direct renin inhibitors, Novartis, in partnership with Swiss biotech firm Speedel, has managed to solve a puzzle that has vexed scientists for more than three decades: How to block rennin, a kidney enzyme that raises blood pressure, at its origin.
Read more...
Bayer to axe 6,100 jobs worldwide after Schering takeover
AFP   Friday, 02 March 2007

Bayer's board chairman Arthur Higgins gestures during a press conference in Berlin. The chemicals and pharmaceuticals giant plans to slash 6,100 jobs worldwide following the takeover of drug maker Schering.(AFP/DDP/File/Clemens Bilan)AFP - German chemicals and pharmaceuticals giant Bayer said Friday that it plans to slash 6,100 jobs worldwide following the takeover of drug maker Schering.


Read more...
Merck's Forecast Fuels Investor Hopes
BusinessWeek Online   Thursday, 01 March 2007
BusinessWeek Online - After withdrawing its arthritis painkiller drug Vioxx from the market in late 2004, Merck & Co. has been struggling to recover by selling new products. Now the New Jersey pharmaceutical company said Feb. 28 that its earnings will be better in 2007 than expected.
Read more...
<< Start < Previous 1 2 3 4 5 6 7 8 9 10 Next > End >>

Results 22 - 42 of 319